BlackRock's Therapeutics Portfolio

Laronde develops an eRNA-based therapeutic platform that is capable of indicating diverse proteins inside the body.

OnKure is a clinical-stage biopharma company developing precision medicines targeting validated cancer drivers.

Arcutis Biotherapeutics is a clinical-stage biopharmaceutical company focused on developing medical dermatology for unmet needs.

Abcuro develops immunotherapies to treat autoimmunity and cancer.

Numab is a biotechnology company that offers antibody-based therapeutics for the treatment of severe diseases.

Bright Peak is a biotech company that develops a portfolio of immunotherapies for the treatment of cancer and autoimmune diseases.

Monte Rosa Therapeutics is a biotechnology company that develops cancer therapeutics that modulate protein degradation pathways.

Cellares is an Integrated Development and Manufacturing Organization dedicated to the automated, large-scale production of cell therapies.

TScan Therapeutics is a biopharmaceutical company focused on the development of immunotherapy treatments for cancer.

Kymera Therapeutics is a biotechnology company that specializes in the field of targeted protein degradation.

Annexon Biosciences is a biotech company, discovering and developing novel therapeutics for neurodegenerative and autoimmune disorders.

Vividion is a developer of a novel drug discovery platform designed to offer transformative treatments to patients with serious illnesses.

Decibel Therapeutics is a hearing company focused on discovering and developing new medicines to protect, repair, and restore hearing.